ACETYLCYSTEINE — all Canadian products
10 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ACETYLCYSTEINE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02534908 | ACETYLCYSTEINE INJECTION | EUGIA PHARMA INC. | Solution | Intravenous | ACETYLCYSTEINE 200 MG | Approved | |
| 02528274 | ACETYLCYSTEINE INJECTION | AURO PHARMA INC | Solution | Intravenous | ACETYLCYSTEINE 200 MG | Approved | |
| 02243098 | ACETYLCYSTEINE SOLUTION | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Inhalation; Oral | ACETYLCYSTEINE 200 MG | Marketed | |
| 02459906 | ACETYLCYSTEINE SOLUTION USP | HIKMA CANADA LIMITED | Solution | Inhalation; Oral; Intravenous | ACETYLCYSTEINE 200 MG | Marketed | |
| 02538431 | ACETYLCYSTEINE SOLUTION USP | STERIMAX INC | Solution | Intravenous; Inhalation; Oral | ACETYLCYSTEINE 200 MG | Marketed | |
| 02300435 | ACETYLCYSTEINE INJECTION | TELIGENT OU | Solution | Oral; Inhalation; Intravenous | ACETYLCYSTEINE 200 MG | Cancelled Post Market | |
| 02091526 | MUCOMYST | WELLSPRING PHARMACEUTICAL CANADA CORP | Solution | Oral; Inhalation; Intravenous | ACETYLCYSTEINE 200 MG | Cancelled Post Market | |
| 00606235 | MUCOMYST INJ 200MG/ML | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Liquid | Oral; Inhalation; Intravenous | ACETYLCYSTEINE 200 MG | Cancelled Post Market | |
| 02181460 | PARVOLEX | MYLAN PHARMACEUTICALS ULC | Liquid | Intravenous; Inhalation; Oral | ACETYLCYSTEINE 200 MG | Cancelled Post Market | |
| 02094738 | PARVOLEX LIQ IV 200MG/ML | BIONICHE PHARMA (CANADA) LTD | Liquid | Intravenous | ACETYLCYSTEINE 200 MG | Cancelled Post Market |
Browse other molecules: